Flaharty Asset Management, LLC Abiomed Inc Transaction History

Flaharty Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$255.22 - $317.0 $331,786 - $412,100	-1,300 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$141.4 - $257.09 $183,820 - $334,216	1,300 New	1,300 $314,000
Q1 2020 May 15, 2020	SELL	$130.51 - $196.01 $169,663 - $254,813	-1,300 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$278.07 - $446.21 $8,620 - $13,832	-31 Reduced 2.33%	1,300 $532,000
Q4 2017 Feb 14, 2018	BUY	$168.78 - $199.74 $5,232 - $6,191	31 Added 2.38%	1,331 $277,000
Q3 2017 Nov 14, 2017	BUY	$145.39 - $168.6 $189,006 - $219,180	1,300	1,300 $226,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Flaharty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Flaharty Asset Management, LLC with notifications on news.